Alexander M. Boyko

Alexander M. Boyko

Auto-generated profile, based on publicly available information

Alexander M. Boyko

Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
YPYu.K. Podoksenov
Yu.K. Podoksenov
MDMaria Diakova
Maria Diakova
ABA.M. Boyko
A.M. Boyko
BKBoris Kozlov
Boris Kozlov
Acute kidney injury (AKI) and its delayed diagnosis often lead to an increase in the number of patients with chronic kidney disease. There is no denying the importance of studying the pathogenetic mechanisms of AKI, timely predictive identification of patients at high risk of CSA-AKI, as well as the need to search for and improve perioperative strategies to prevent CSA-AKI. The development of new approaches regarding predictive diagnostics of AKI and their widespread introduction into a wide clinical practice will improve the prognosis and survival of these patients.The modern diagnostic continuum of AKI considers risk factors as pre-existing conditions against which adverse factors of the perioperative period are realised. Risk factors for AKI in cardiac surgery are divided into two categories: 1) patient-dependent and 2) operations-associated or modifiable risk factors for the development of AKI, to some extent secondary to iatrogenic effects (adverse factors of the perioperative period). A clear understanding of the significance of these factors regarding the development of AKI in cardiac surgery patients allows us to form risk scales for predicting CSA-AKI in the postoperative period. This review presents the following work, which is a milestone for the predictive diagnosis of AKI in cardiac surgery: model Association of Nephrology and the Association of Anaesthesiologists and Reanimatologists of Russia, the scale EuroSCORE II, the STS Score, Score Mehta, ‘risk index perioperative renal dysfunction/failure’, S. Aronson et al., scale S.Y. Ng et al., model K. Birnie et al.The use of predictive models for the predictive diagnosis of CSA-AKI is an important strategy for identifying high-risk patients. This approach allows active application of preventive strategies regarding AKI in routine clinical practice. It also has distinct advantages regarding conducting cohort clinical studies of new renoprotective technologies. To date, there is no ‘gold standard’ scale for predicting the risk of cardiac AKI. The authors propose consideration of their application as a weighted ‘Solomon’ solution, according to a specific clinical situation.Received 10 July 2020. Revised 9 September 2020. Accepted 10 September 2020.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Author contributionsConception and design: N.O. Kamenshchikov, Yu.K. Podoksenov, M.L. DiakovaDrafting the article: N.O. Kamenshchikov, M.L. Diakova, A.M. BoykoCritical revision of the article: M.L. Diakova, Yu.K. PodoksenovFinal approval of the version to be published: N.O. Kamenshchikov, Yu.K. Podoksenov, M.L. Diakova, A.M. Boyko, B.N. Kozlov

30 December 2020 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
YPYu. Podoksenov
Yu. Podoksenov
MDMaria Diakova
Maria Diakova
ABA. Boyko
A. Boyko
BKBoris Kozlov
Boris Kozlov
АБА. М. Бойко
А. М. Бойко
Surgical intervention on an ‘open’ heart during cardio-pulmonary bypass is the method of choice for patients with valvular defects, complicated forms of coronary heart disease and combined pathology. The level of perioperative mortality in these interventions range from 2 % to 10 %. Acute kidney injury associated with cardiac surgery is a common and serious complication which dramatically worsens operative prognoses and results. According to several major studies, the incidence of acute renal injury in cardiac surgery is comparable with the incidence of myocardial infarction, with corresponding unsatisfactory outcomes.The introduction of the term ‘acute kidney injury’ into clinical practise, replacing the concept of acute renal failure, occurred relatively recently. This facilitated a universal definition for this condition, and unified the criteria for diagnosis and stratification of acute renal dysfunction severity. The article defines acute kidney injury using RIFLE, AKIN and KDIGO criteria. Acute kidney injury in cardiac surgery dramatically worsens short-term results and long-term outcomes, and thus increases the economic cost of treating patients. According to some reports, in industrialised countries, the health costs associated with acute kidney injury are estimated at $ 1 billion. Acute kidney injury is associated with approximately 300,000 deaths per annum, as well as approximately 300,000 new cases of chronic kidney disease. Cumulative expenses associated with acute renal injury in cardiac surgery are not directly limited to the hospitalisation period, but are often prolonged and/or deferred. These patients require additional financial expenses after discharge from hospital, which once again exemplifies this problem in cardiac surgery.Manifest acute kidney injury in the postoperative period of cardiac surgery leads to an increased number of extrarenal complications, reduced short-and long-term survival rates, increased economic costs in hospitals and prolonged treatment effects in the long-term. The introduction of a single definition of cardiac acute renal injury according to KDIGO criteria into clinical practise will identify patient groups with a high risk of developing this pathology. Similarly, it will also facilitate timely measures to prevent the development of complications in postoperative periods, which will reduce the risk of complications in cardiac patients.Received 10 July 2020. Revised 2 September 2020. Accepted 9 September 2020.Funding: The study did not have sponsorship.Conflict of interest: Authors declare no conflict of interest.Author contributionsConception and design: N.O. Kamenshchikov, Y.K. Podoksenov, M.L. DiakovaData collection and analysis: N.O. Kamenshchikov, A.M. Boyko, M.L. DiakovaDrafting the article: N.O. Kamenshchikov, M.L. Diakova, A.M. BoykoCritical revision of the article: M.L. Diakova, Y.K. PodoksenovFinal approval of the version to be published: N.O. Kamenshchikov, Y.K. Podoksenov, M.L. Diakova, A.M. Boyko, B.N. Kozlov

12 December 2022 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
BKBoris Kozlov
Boris Kozlov
DPDmitri S Panfilov
Dmitri S Panfilov
BBB. A. Bazarbekova
B. A. Bazarbekova
ESE. L. Sonduev
E. L. Sonduev
ABA. M. Boiko
A. M. Boiko
Introduction. Ascending aortic aneurysms with bicuspid and tricuspid aortic valves have completely diff erent nature of origin. There is a large number of studies focusing on the negative effect of bicuspid aortic valve on the prognosis of this disease. However, studies regarding the impact of tricuspid aortic valve on ascending aortic aneurysms are extremely rare. In this regard, the purpose of our work was.Aim: To analyze the early results of simultaneous surgical treatment.Material and Methods. The retrospective study included 73 patients with aortic valve stenosis in combination with ascending aortic aneurysm. Patients were divided into two groups: group 1 comprised patients with bicuspid aortic valve and aortic aneurysm; group 2 comprised patients with tricuspid aortic valve and aortic aneurysm. All the examined patients underwent prosthetics of the aortic valve with simultaneous prosthetics of the ascending aorta as planned. Echocardiographic parameters and multispiral computed aortography were evaluated before and after surgery.Results. The patients were comparable in baseline characteristics. The incidence rates of acute cerebrovascular accident, respiratory failure requiring prolonged respiratory support, acute kidney injury, and bleeding requiring re-operation were 3.7 vs. 0% (p = 0.918), 1.9 vs. 0% (p = 0.492), 1.9% vs. 0% (p = 0.492), and 0% vs. 5.3% (p = 0.128) in groups 1 and 2, respectively. There was no hospital mortality in any of study groups. There was no aortic valve prosthesis dysfunction in the early postoperative period.Conclusion. Reconstructive surgeries for ascending aortic aneurysm with simultaneous prosthetics of the tricuspid aortic valve were characterized by satisfactory immediate clinical results comparable to patients with a bicuspid aortic valve.

29 September 2023 in Fundamental and Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABA. M. Boyko
A. M. Boyko
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
AMA. G. Miroshnichenko
A. G. Miroshnichenko
YPYu. K. Podoksenov
Yu. K. Podoksenov
OSOlga Serebryakova
Olga Serebryakova
BKBoris Kozlov
Boris Kozlov
Aim. To evaluate the efficiency and safety of nitric oxide delivery for kidney protection in the simulation of cardiopulmonary bypass and circulatory arrest in the experiment.Materials and Methods. We performed an experimental modeling of cardiopulmonary bypass with circulatory arrest in 20 sheep of the Altai breed weighing 30-32 kg. Circulatory arrest was performed at moderate hypothermia (30-32°C) for 15 minutes and was followed by reperfusion and warming up to 37°C. Animals were divided into 2 equal groups: 10 sheep which received nitric oxide (NO) through the inhalations supply and cardiopulmonary bypass machine at a dose of 80 ppm, and 10 control sheep. We further collected biological fluids and tissue specimens for subsequent assessment of the safety of NO use and its nephropro-tective properties.Results. The proposed method of NO therapy during the cardiopulmonary bypass with circulatory arrest was safe and did not lead to an increase in toxic metabolites. In sheep which received NO therapy, the average concentration of NO2 throughout the entire period of the experiment was 1.2 ± 0.19 ppm (with a maximum allowable concentration of 3.0 ppm), and the concentration of methemoglobin (MetHb) was 2.3 ± 0.34% (with a maximum allowable level of 5.0%). Neutrophilic gelatinase-associated lipocalin (NGAL) was significantly lower in sheep which received NO therapy (0.67 ± 0.255 ng/mL versus 2.23 ± 0.881 ng/mL in the control group, p = 0.0001). Acute kidney injury was mitigated in sheep which received NO therapy.Conclusion. Experimental delivery of NO at a dose of 80 ppm during the cardiopulmonary bypass and circulatory arrest is safe and is associated with reduced acute kidney injury.

6 October 2026 in Russian Journal of Cardiology and Cardiovascular Surgery
Verified
Journal Article
Closed access
MDMaria Diakova
Maria Diakova
YSYu.S. Svirko
Yu.S. Svirko
DPDmitri S Panfilov
Dmitri S Panfilov
TSTatiana E. Suslova
Tatiana E. Suslova
YPYu.K. Podoksenov
Yu.K. Podoksenov
BKBoris Kozlov
Boris Kozlov
Objective. To analyze endothelial glycocalyx damage markers in reconstructive thoracic aortic surgery under cardiopulmonary bypass and circulatory arrest (CA), and to identify correlations with postoperative pneumonia. Material and methods. This study included 39 patients with thoracic aortic disease requiring reconstructive surgery under CA and unilateral antegrade cerebral perfusion. Serum biochemical markers of endothelial glycocalyx damage — syndecan-1 (SDC-1), heparan sulfate proteoglycan (HSPG), and hyaluronic acid (HA) — were analyzed intraoperatively and in early postoperative period. Postoperative course and incidence of pneumonia were assessed. Results. The ROC analysis revealed risk factors of pneumonia depending on serum HA after 4 and 24 postoperative hours. Higher risk of pneumonia followed HA >51.67 ng/mL after 4 hours (sensitivity 72.7%, specificity 85.7%) and >48.29 ng/mL after 24 hours (sensitivity 72.7%, specificity 71.4%). Conclusion. Identifying early predictors of pneumonia in thoracic aortic surgery is clinically relevant. Elevated HA can be considered an early predictor of postoperative pneumonia, potentially enabling initiation of timely targeted prophylaxis to mitigate this complication.

15 April 2024 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
ABA.M. Boyko
A.M. Boyko
NKNikolay O. Kamenshchikov
Nikolay O. Kamenshchikov
AMA.G. Miroshnichenko
A.G. Miroshnichenko
YPYu.K. Podoksenov
Yu.K. Podoksenov
YSYu.S. Svirko
Yu.S. Svirko
BKBoris Kozlov
Boris Kozlov
Introduction: Surgical interventions under cardiopulmonary bypass and circulatory arrest are complicated by impaired microcirculation in tissues; during hypoxic period the mitochondria dysfunction becomes the leading pathogenetic factor of ischemia-reperfusion injuries. In this regard, the search for methods of organ protection seems to be an extremely urgent task. The using of nitric oxide can be a promising technique given its pluripotent properties.Objective: The study was aimed to examining of mitochondria injuries in kidney biopsies stipulated by cardiopulmonary bypass and circulatory arrest when simulating cardiac surgery, as well as to assessing the potentials of organ protection with nitric oxide in the experiment.Methods: The study was carried out on Altai breed sheep and included simulating of cardiopulmonary bypass and circulatory arrest. The first group (n = 6) was provided with intraoperative nitric oxide donation. The second group (n = 6) served as a control (without nitric oxide donation). Mitochondria injuries were assessed in kidney biopsies by measuring transmembrane potential and Ca2+-binding capacity of organelles, as well as by determining ATP and lactate concentrations.Results: Nitric oxide therapy was associated with less mitochondria dysfunction in kidney biopsies compared with the control group. There was a steady trend to the amelioration of the energy maintenance in the renal parenchyma in the nitric oxide donation group.Conclusion: A steady trend towards optimizing the energy supply of tissues under cardiopulmonary bypass and circulatory arrest was revealed in an experiment against the background of NO donation at a concentration of 80 ppm. Received 11 February 2024. Revised 28 March 2024. Accepted 29 March 2024. Funding: The The study was carried out within the framework of the state assignment “Protection of organs by nitric oxide in cardiovascular surgery: technological support (synthesis and delivery devices), mechanisms for implementing protective effects and impact on clinical outcomes” (topic No. 122123000017-3). Conflict of interest: The authors declare no conflict of interest. Contribution of the authors Conception and study design: A.M. Boyko, N.O. Kamenshchikov, Yu.K. Podoksenov, L.N. Maslov, B.N. Kozlov Data collection and analysis: A.M. Boyko, Yu.S. Svirko, V.A. Lugovskiy, A.V. Mukhomedzyanov, B.A. BazarbekovaStatistical analysis: I.V. KravchenkoDrafting the article: A.M. Boyko Critical revision of the article: N.O. Kamenshchikov, A.G. Miroshnichenko, Yu.K. Podoksenov, M.L. Diakova, K.A. Petlin, D.S. Panfilov, B.N. KozlovFinal approval of the version to be published: A.M. Boyko, N.O. Kamenshchikov, A.G. Miroshnichenko, Yu.K. Podoksenov, Yu.S. Svirko, V.A. Lugovskiy, M.L. Diakova, I.V. Kravchenko, A.V. Mukhomedzyanov, L.N. Maslov, B.A. Bazarbekova, K.A. Petlin, D.S. Panfilov, B.N. Kozlov